Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfectedin CHO cells

Citation
M. Tonacchera et al., Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfectedin CHO cells, EUR J ENDOC, 144(6), 2001, pp. 611-618
Citations number
21
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
EUROPEAN JOURNAL OF ENDOCRINOLOGY
ISSN journal
08044643 → ACNP
Volume
144
Issue
6
Year of publication
2001
Pages
611 - 618
Database
ISI
SICI code
0804-4643(200106)144:6<611:AFPWAT>2.0.ZU;2-Y
Abstract
Objective: The human sodium iodide symporter (hNIS) is a candidate autoanti gen in autoimmune thyroid diseases. To investigate the possible existence o f autoantibodies able to interfere with the biological activity of hNIS, an assay was developed using a cell line stably expressing hNIS. Methods: hNIS complementary cDNA cloned in pcDNA3 and a neomycin resistance gene vector were co-transfected into CHO cells. After selection with genet icin, a cell line termed PA(4). showing the highest level of (NaI)-I-125 up take, was characterized. The time course of iodide uptake was evaluated by incubating PA(4) cells with 10 mu mol/l NaI and 0.1 mu Ci (NaI)-I-125 for a period up to 90 min. The accumulation of iodide increased linearly between 2 and 10 min, reaching a plateau at 45 min. The curve of iodide efflux mir rored that of iodide influx. Both perchlorate and thiocyanate inhibited iod ide uptake in PA(4) cells in a dose-dependent manner starting from concentr ations as low as 0.01 and 0.1 mu mol/l respectively and complete inhibition was obtained at concentrations of 100 mu mol/l perchlorate and 1000 mu mol /l thiocyanate. The sensitivity of the inhibition assay was further improve d using both inhibitors after 5 min incubation and in the absence of cold N aI. Results: Included in the study were 42 patients with Graves' disease (25 ha d active hyperthyroidism, ten were euthyroid and seven had hypothyroidism); 34 patients with Hashimoto's thyroiditis (one was euthyroid, four had subc linical hypothyroidism and 29 were overtly hypothyroid): and 19 with atroph ic thyroiditis (all hypothyroid). Four out of eight whole sera from patients with Hashimoto's thyroiditis, an d 8 out of 25 whole sera from patients with Graves' disease caused an inhib ition of iodide uptake in PA(4) cells greater than 20% but also in 4 out of 15 sera from normal subjects. This inhibition activity exerted by sera fro m patients and controls was lost after dialyzing against buffer. Accordingl y, IgGs purified from sera of all patients with Graves' disease and with Ha shimoto's thyroiditis or atrophic thyroiditis were devoid of any effect on iodide uptake. Conclusions: In conclusion, we believe that autoantibodies able to block th e function of hNIS are very rare.